aspirin has been researched along with diazeniumdiolate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, H; Lee, SH; Mollica, MY; Velázquez-Martínez, CA; Wang, L; Wu, S | 1 |
| Basudhar, D; Bharadwaj, G; Caceres, VM; Cheng, RY; Heinecke, JL; Holland, RJ; Jain, S; Miranda, KM; Paolocci, N; Ridnour, LA; Shi, S; Spadari-Bratfisch, RC; Velázquez-Martínez, CA; Wink, DA | 1 |
| Basudhar, D; Bharadwaj, G; Cheng, RC; Miranda, KM; Ridnour, LA; Wink, DA | 1 |
3 other study(ies) available for aspirin and diazeniumdiolate
| Article | Year |
|---|---|
Effects of nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NONO-NSAIDs) on melanoma cell adhesion.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Azo Compounds; Cell Adhesion; Cell Line, Tumor; Cell Movement; Fibronectins; Flow Cytometry; Humans; Integrins; Melanoma; Naproxen; Neoplasm Metastasis; Nitric Oxide; Nitric Oxide Donors; Receptors, Very Late Antigen; Vascular Cell Adhesion Molecule-1; Wound Healing | 2012 |
Synthesis and chemical and biological comparison of nitroxyl- and nitric oxide-releasing diazeniumdiolate-based aspirin derivatives.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Azo Compounds; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Cells, Cultured; Cyclooxygenase 2; Enzyme Inhibitors; Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+); Humans; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Models, Chemical; Molecular Structure; Myocytes, Cardiac; Nitric Oxide; Nitrogen Oxides; Prodrugs; Sarcomeres | 2013 |
Chemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer.
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Azo Compounds; Blotting, Western; Breast Neoplasms; Cell Movement; Cell Proliferation; Cyclooxygenase 2; Female; Humans; Mice; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides; Prodrugs; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |